본문 바로가기
KERD
논문KCI 등재

內消沃雪湯이 항암 및 면역에 미치는 영향

Effects of NaisoOkseol-Tang (NOT) on solid tumor and immunity

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류한의학

초록

Objective : The present study was carried out to investigate the effects of NaisoOkseol-Tang (NOT) on solid tumor in mice in terms of immune-potentiating and direct cytotoxic action of NOT in vitro and vivo study. Methods : The present author investigated thymocyte proliferation and NO production to confirm immune-potentiating activity of NOT and also investigated body/tumor weight and survival rates in tumor bearing mice. In this study, administration of NOT decreased tumor/weight ratio significantly, and prolonged survival duration compared to non-treated control. Treatment with NOT also elevated proliferation rates of thymocytes isolated from tumor bearing mice. Results : In vitro study, treatment with NOT suppressed proliferation rate of Sarcoma 180 (S-180) cells. Contrary, treatment with NOT elevated proliferation rate of thymocytes. These results were co-related with in vivo study. In addition, NO production from abdominal macrophages isolated from normal mice was not affected by treatment with NOT. Conclusion : NOT is useful to treat patient with solid tumor, because NOT has direct toxic action for tumor cell and immune-potentiating action for T cells.

Abstract

Objective : The present study was carried out to investigate the effects of NaisoOkseol-Tang (NOT) on solid tumor in mice in terms of immune-potentiating and direct cytotoxic action of NOT in vitro and vivo study. Methods : The present author investigated thymocyte proliferation and NO production to confirm immune-potentiating activity of NOT and also investigated body/tumor weight and survival rates in tumor bearing mice. In this study, administration of NOT decreased tumor/weight ratio significantly, and prolonged survival duration compared to non-treated control. Treatment with NOT also elevated proliferation rates of thymocytes isolated from tumor bearing mice. Results : In vitro study, treatment with NOT suppressed proliferation rate of Sarcoma 180 (S-180) cells. Contrary, treatment with NOT elevated proliferation rate of thymocytes. These results were co-related with in vivo study. In addition, NO production from abdominal macrophages isolated from normal mice was not affected by treatment with NOT. Conclusion : NOT is useful to treat patient with solid tumor, because NOT has direct toxic action for tumor cell and immune-potentiating action for T cells.

참고문헌 (58)

  1. 孫淑英, "한방내과학", pp.178~179 (1991), 서울. 성보사
  2. 김진성, "종양의 예방과 치료를 위한 식이요법", 대한한방종양회지, 1(1), pp.231~ (1995)
  3. 徐政周, "한의학적 진단유형에 따른 한약방제의 항암 및 면역조절작용에 미치는 영향", 동의병리학회지, 9, pp.1~20 (1994)
  4. 黃奎東, "噎膈·反胃와 胃癌과의 相關性에 대한 文獻的 考察", 大韓韓方腫瘍學會誌, 1(1), pp.129~ (1995)
  5. 上海中醫學院編, "中醫內科學", pp.90~ (1983), 商務印書館
  6. 上海中醫學院編, "中醫外科學", pp.302~309 (1982), 商務印書館
  7. 沈連生, "老人保健中成藥", pp.210~211 (1983), 北京. 人民衛生出版社
  8. 張代劉, "中西醫結合治療癌症", pp.210~211 (1993), 山西人民出版社
  9. 厲暢, "癌의 中醫治療", 東洋醫學, 18(1), pp.56~ (1992)
  10. 陳實功, "外科正宗", pp.115~ (1977), 瀋陽. 요령과학기술출판사
  11. 祁坤, "外科大成", pp.198~ (1987), 대북. 문광도서유한공사
  12. 誤謙, "醫宗金鑑(下)", pp.443~ (1982), 북경. 인민위생출판사
  13. 崔昇勳, "동의종양학", pp.13~42 (1984), 서울. 성보사
  14. 서울대학교 의과대학, "종양학", pp.43~93 (1996), 서울. 서울대학교 출판부
  15. 예방의학과 공중보건 편찬위원회, "예방의학과공중보건", pp.426~430 (1987), 서울. 계축문화사
  16. Astrow, A. B, "Rethinking cancer", pp.343~498 (1994), Lancet
  17. 龔信纂, "古今醫鑑", pp.35~ (1999), 中國. 中國中醫藥出版社
  18. 陳實功, "外科正宗", pp.28~ (1983), 北京. 人民衛生出版社
  19. 고홍개, "內消沃雪湯의 抗癌效果", 한방안이비인후피부과학회지, 18(1), pp.82~93 (2005), 대한한방안이비인후피부과학회
  20. Wysocki, L.J, ""Planning" for lymphocytes ; A method for cell selection", Proc. Nat1. Acad. Sci. USA, 75(6), pp.2844~2848 (1978)
  21. Mizel, S.B, "Regulation of lymphocyte-activating factor (LAF) production and secretion in P388D1 cells ; identification of high molecular weight precursors of LAF", J. Immunol. Methods, 122(6), pp.2173~2179 (1979)
  22. Mosmann, T, , J. Immunol. methods, pp.55~65 (1983)
  23. Kotnic, V, , J. Immunol. method, 129(1), pp.23~30 (1990)
  24. Rockett, K.A, "Killing of Plasmodium falciparum in vitro by nitric oxide derivatives", Infect.Immun, 59(9), pp.3280~3283 (1991)
  25. 문구, "암 동서의 결합치료1", pp.35~257 (1999), 원광대학교 출판국
  26. Astrow, A. B, "Rethinking cancer", pp.343~498 (1994), Lancet
  27. Bailer, J. C, "Cancer undefeated", N. Eng. J. Med, 336, pp.1569~1574 (1997)
  28. Lopes, . C, "Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype", Leukemia Res, 27(5), pp.413~423 (2003)
  29. 한홍준, "秘方奪命散의 항산화 항암 항균 효과 연구", 한방안이비인후피부과학회지, 20(1), pp.115~129 (2007), 대한한방안이비인후피부과학회
  30. 유미경, "化氣調經湯의 항산화 및 항암 효과", 한방안이비인후피부과학회지, 20(1), pp.80~98 (2007), 대한한방안이비인후피부과학회
  31. 이정호, "어성초 돌콩 추출물의 항암활성 및 항산화 활성 효과", 한방안이비인후피부과학회지, 18(3), pp.37~43 (2005), 대한한방안이비인후피부과학회
  32. 강문여, "仙傳化毒湯이 癌細胞 및 免疫細胞 增殖에 미치는 實驗的 效果- 항암제 병용효과를 중심으로 -", 한방안이비인후피부과학회지, 18(1), pp.104~115 (2005), 대한한방안이비인후피부과학회
  33. 東軒居士, "衛濟寶書(中國醫學大系)", pp.817~ (1987), 서울. 靑談出版社 9권
  34. 楊維傑, "黃帝內經素問靈樞譯解", pp.235~262 (1980), 서울. 成輔社,(素問)
  35. 李聰甫, "金元四大醫家 學術思想硏究", pp.36~37 (1985), 서울. 成輔社
  36. 李東垣, "東垣十種醫書", pp.532~533 (1994), 서울. 大星文化社
  37. 朱丹溪, "丹溪心法附餘.臺灣", pp.10~ (1963), 五洲出版社. 卷十六
  38. 洪元植, "現代中國의 癌治療法", pp.17~388 (1980), 서울. 영문사
  39. 邱佳信, "惡性腫瘤服藥方法的實驗硏究", pp.985~ (1989), 중국. 浙江中醫雜誌
  40. 楊貴貞, "人蔘抗小鼠手術應激的細胞免疫調節效應", pp.479~480, 中西醫結合雜誌. 8.
  41. 許繼平, "惡性腫瘤氣虛陰虛證患者免疫功能觀察", pp.744~ (1983), 浙江中醫雜誌 7
  42. 林宗廣, "扶正培本法治療中晩期原發性肝癌 31例", pp.7~ (1984), 上海中醫藥雜誌. 2
  43. 楊金神, "健脾理氣淸熱解毒軟堅化痰方劑治療晩期肝癌的臨床觀察及實驗究", pp.275~ (1987), 中西醫結合雜誌. 7
  44. 上海中醫學院編, "中醫外科學", pp.24~30 (1981), 香淃. 上海印書館
  45. 顧伯華, "實用中醫外科學", pp.79~81 (1985), 上海. 上海科學技術出版社
  46. 辛民敎, "臨床本草學", pp.69~636 (1997), 서울. 永林社
  47. Thomas Kindt, "Kuby immunology", York:W.H. Freeman and Company, 6, pp.351~367 (2006)
  48. Gilboa E, "DC-based cancer vaccines", Clin Invest, 117(5), pp.1195~1203 (2007)
  49. Zhang T, "receptor-bearing T cells mediate antitumor immunotherapy", Blood, 106(5), pp.1544~1551 (2005)
  50. van den Broeke LT, "Dendritic cell-induced activation of adaptive and innate antitumor immunity", J Immunol, 171(11), pp.5842~5852 (2003)
  51. H. W. Kim, "Therapeutic Efficacy of extracts from root of Acanthopanax Sessiliflorus as anti-cancer drug; in vivo and vitro study", Korean J. Oriental physialogy & pathology, 21(2), pp.518~522 (2007)
  52. 백원칠, "운동량이 NK Cell 및 LAK Cell 의 활성도 , 복강암 마우스의 생존기간에 미치는 영향", 한국체육학회지, 40(4), pp.719~728 (2001)
  53. 김형우, "방사선이 조사된 오갈피 나무의 추출물이 생쥐의 복강암 및 면역세포에 미치는 영향", 동의생리병리학회지, 21(3), pp.736~740 (2007), 대한동의병리학회
  54. Ozge C, "Massive pleural effusion in an 18-year-old girl with Ewing sarcoma", Can Respir J, 11(5), pp.363~365 (2004)
  55. Kriukova IN, "Expression ofThy 1 thymocyte differentiation antigen in mouse mammary cancer cells in vitro", Biull Eksp Biol Med, 96(8), pp.81~84 (1983)
  56. Webb SD, "Macrophage-based anti-cancer therapy: modelling different modes of tumour targeting", Bull Math Biol, 69(5), pp.1747~1776 (2007)
  57. Hicks AM, "Effector mechanisms of the anti-cancer immune responses of macrophages in SR", CR mice, 2006, pp.31(6), 11~
  58. Dwyer JM, "The use of concanavalin A to study the immunoregulation of human T cells", Clin Exp Immunol, 46(2), pp.237~249 (1981)

관련 논문AI추천

이 간행물의 다른 논문 (11건)